New diabetes pill shows Real-World promise in blood sugar control
NCT ID NCT04601740
First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 32 times
Summary
This study tracked 145 adults with type 2 diabetes in the Netherlands who were prescribed oral semaglutide (Rybelsus) by their doctors. Researchers measured changes in blood sugar levels and body weight over 8-10 months. Participants also filled out questionnaires about how they took their medication. The goal was to see how well the drug works in everyday life, not just in a lab.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre Netherlands
Alphen aan den Rijn, 2408 AV, Netherlands
Conditions
Explore the condition pages connected to this study.